← Eichor
Study identifier: NCT06649357 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Comparison Between Bipolar Transurethral Resection of the Prostate and Moses Assisted Holmium Laser Enucleation of the Prostate

Condition: Prostate Hyperplasia · Surgery · Endoscopic Anatomical Enucleation of the Prostate (EEAP)  ·  Sponsor: Fundacio Puigvert

PhaseNA
Planned participants130
Who can joinMale, N/A to no upper limit
Healthy volunteersNo

About this study

Introduction: Multiple studies have demonstrated the superiority of HoLEP in aspects such as transfusión rates or postoperative stay. On the other hand, no differences have been observed in terms of functional outcomes between both techniques, and surgical times reported in different studies tend to be longer for HoLEP. These results likely contribute to TURP, especially with bipolar energy (Bi-TURP), continuing to be considered by many the gold standard for surgical treatment of BPH. Sofware and hardware upgrades to the Lumenis Pulse 120H. system in 2017, delivered MOSES 2.0, a single-use laser fibre used to perform MOSES augmented HoLEP (MoLEP). MoLEP has shown to be superior in intraoperative outcomes when compared to traditional HoLEP. The availability of new morcellators might also decrease surgical time for HoLEP. This changing landscape for BPH endoscopic surgery deserves a re-evaluation of the differences between Bi-TURP and MoLEP. Primary Objective: To compare the hospital stay of patients of patients undergoing MoLEP with those undergoing Bi-TURP. Secondary objectives: * To compare the surgical time of MoLEP with that of Bi-TURP. * To compare the bladder catheterization time aCer MoLEP with that of Bi-TURP. * To compare the postoperative complication rate patients undergoing MoLEP with those undergoing Bi-TURP. * To compare functional results of patients undergoing MoLEP with those undergoing Bi-TURP. This study is a prospective multicentric randomized and cont…

This description comes directly from the study's public registry record.

Talk to the study team

Ivan Schwartzmann Jochamowitz, MD  ·  0034934169700  ·  ischwartzm@fundacio-puigvert.es

Silvia Mateu, MD  ·  0034934169700  ·  smateu@fundacio-puigvert.es

Always discuss trial participation with your own doctor first.

Locations (6)

Complejo Hospitalario Universitario de Santiago de CompostelaSantiago de Compostela, A Coruña, SpainRecruiting
Fundacio PuigvertBarcelona, BARCELONA, SpainRecruiting
Hospital Univesitari de BellvitgeL'Hospitalet de Llobregat, BARCELONA, SpainNot Yet Recruiting
Hospital Universitario Marqués de ValdecillasSantander, Cantabria, SpainRecruiting
Hospital Universitario de CabueñesGijón, Principality of Asturias, SpainRecruiting
Hospital Universitario Río HortegaValladolid, Valladolid, SpainRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06649357